(Q38994042)

8 September 2017

title

Multifunctional theranostic red blood cells for magnetic-field-enhanced in vivo combination therapy of cancer (English)

1 reference

8 September 2017

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24838472%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Xiaoqi Sun

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24838472%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Guangbao Yang

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24838472%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Zhuang Liu

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24838472%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

author name string

Liang Cheng

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24838472%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Shengnan Yin

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24838472%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Yonggang Li

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24838472%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

language of work or name

English

0 references

publication date

19 May 2014

1 reference

8 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24838472%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24838472%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

issue

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24838472%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

page(s)

4794-4802

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24838472%20AND%20SRC:MED&resulttype=core&format=json

Combination versus single agent chemotherapy: A review of the basis for selection of drug treatment of cancer

3 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201400158

Evolutionary dynamics of cancer in response to targeted combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201400158

Cancer nanotechnology: opportunities and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201400158

Nanoparticle therapeutics: an emerging treatment modality for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201400158

Therapeutic nanoparticles for drug delivery in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201400158

Nanoparticles of biodegradable polymers for new-concept chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201400158

Theranostic nanoparticles with controlled release of gemcitabine for targeted therapy and MRI of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201400158

Carbon Nanotubes in Biology and Medicine: In vitro and in vivo Detection, Imaging and Drug Delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201400158

Cancer nanomedicine: from drug delivery to imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201400158

Factors that control the circulation time of nanoparticles in blood: challenges, solutions and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201400158

Nanomedicine--challenge and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201400158

Seven challenges for nanomedicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201400158

Drug, enzyme and peptide delivery using erythrocytes as carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201400158

Bacterial ghosts as carrier and targeting systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201400158

Bio-inspired, bioengineered and biomimetic drug delivery carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201400158

Drug delivery by red blood cells: vascular carriers designed by mother nature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201400158

Red blood cells and polyelectrolyte multilayer capsules: natural carriers versus polymer-based drug delivery vehicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201400158

Carrier erythrocytes: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201400158

Erythrocyte-based drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201400158

Magnetite-loaded carrier erythrocytes as contrast agents for magnetic resonance imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201400158

Human erythrocytes as nanoparticle carriers for magnetic particle imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201400158

Gold nanoparticle-incorporated human red blood cells (RBCs) for X-ray dynamic imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201400158

Nanoplasmonics for dual-molecule release through nanopores in the membrane of red blood cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201400158

Human erythrocytes covered with magnetic core-shell nanoparticles for multimodal imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201400158

Surface-modified loaded human red blood cells for targeting and delivery of drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201400158

PEG-functionalized iron oxide nanoclusters loaded with chlorin e6 for targeted, NIR light induced, photodynamic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201400158

Photosensitizer-conjugated magnetic nanoparticles for in vivo simultaneous magnetofluorescent imaging and targeting therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201400158

Monodisperse MFe2O4 (M = Fe, Co, Mn) nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201400158

Magnetic targeting for site-specific drug delivery: applications and clinical potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201400158

Imaging-Guided pH-Sensitive Photodynamic Therapy Using Charge Reversible Upconversion Nanoparticles under Near-Infrared Light

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201400158

21 January 2018

Identifiers

DOI

10.1002/ADMA.201400158

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24838472%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

1 reference